BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milich DR. Pathobiology of acute and chronic hepatitis B virus infection: an introduction. J Viral Hepat 1997;4:25-30. [DOI: 10.1111/j.1365-2893.1997.tb00177.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Block TM, Guo H, Guo JT. Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis. 2007;11:685-706, vii. [PMID: 17981225 DOI: 10.1016/j.cld.2007.08.002] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 7.1] [Reference Citation Analysis]
2 Vandepapelière P. THERAPEUTIC VACCINES FOR CHRONIC HEPATITIS B INFECTION. Sexually Transmitted Diseases. Elsevier; 2000. pp. 309-38. [DOI: 10.1016/b978-012663330-6/50015-2] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
3 Owiredu WK, Kramvis A, Kew MC. Molecular analysis of hepatitis B virus genomes isolated from black African patients with fulminant hepatitis B. J Med Virol. 2001;65:485-492. [PMID: 11596083 DOI: 10.1002/jmv.2062] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
4 Zeng Z, Guan L, An P, Sun S, O’Brien SJ, Winkler CA. A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis. 2008;8:1. [PMID: 18171470 DOI: 10.1186/1471-2334-8-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
5 Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G. Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J Gen Virol 2002;83:1281-9. [PMID: 12029142 DOI: 10.1099/0022-1317-83-6-1281] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
6 Sterneck M, Kalinina T, Günther S, Fischer L, Santantonio T, Greten H, Will H. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology. 1998;28:1390-1397. [PMID: 9794926 DOI: 10.1002/hep.510280530] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
7 Jan RH, Lin YL, Chen LK, Huang MT, Wang LC, Chiang BL. Hepatitis B virus surface antigen can activate dendritic cells and modulate T helper type immune response. Microbiol Immunol. 2011;55:51-59. [PMID: 21175774 DOI: 10.1111/j.1348-0421.2010.00284.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
8 Sajjad M, Ali S, Baig S, Sharafat S, Khan BA, Khan S, Mughal MN, Abidi SH. HBV S antigen evolution in the backdrop of HDV infection affects epitope processing and presentation. J Med Virol 2021;93:3714-29. [PMID: 33289144 DOI: 10.1002/jmv.26711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Block TM, Mehta AS, Blumberg BS, Dwek RA. Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity? DNA Cell Biol 2006;25:165-70. [PMID: 16569195 DOI: 10.1089/dna.2006.25.165] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
10 Lee KA, Song YC, Kim GY, Choi G, Lee YS, Lee JM, Kang CY. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells. Eur J Immunol. 2012;42:1685-1694. [PMID: 22585464 DOI: 10.1002/eji.201142322] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jarrosson L, Kolopp-Sarda MN, Aguilar P, Béné MC, Lepori ML, Vignaud MC, Faure GC, Kohler C. Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses. Vaccine. 2004;22:3789-3796. [PMID: 15315860 DOI: 10.1016/j.vaccine.2004.02.046] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
12 Jan RH, Lin YL, Chen CJ, Lin TY, Hsu YC, Chen LK, Chiang BL. Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase mediated signaling. Microbiol Immunol. 2012;56:719-727. [PMID: 22853328 DOI: 10.1111/j.1348-0421.2012.00496.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
13 Hultgren C, Weiland O, Milich DR, Sällberg M. Cell-Mediated Immune Responses and Loss of Hepatitis B e-Antigen (HBeAg) during Successful Lamivudine and Famciclovir Combination Therapy for Chronic Replicating Hepatitis B Virus Infection. Clinical Infectious Diseases 1999;29:1575-7. [DOI: 10.1086/313518] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ahlén G, Sällberg M, Frelin L. Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse models. Methods Mol Biol 2013;940:239-67. [PMID: 23104348 DOI: 10.1007/978-1-62703-110-3_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Hempel F, Lau J, Klingl A, Maier UG. Algae as protein factories: expression of a human antibody and the respective antigen in the diatom Phaeodactylum tricornutum. PLoS One 2011;6:e28424. [PMID: 22164289 DOI: 10.1371/journal.pone.0028424] [Cited by in Crossref: 106] [Cited by in F6Publishing: 85] [Article Influence: 9.6] [Reference Citation Analysis]
16 Biburger M, Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J Immunol. 2005;175:1540-1550. [PMID: 16034092 DOI: 10.4049/jimmunol.175.3.1540] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 6.8] [Reference Citation Analysis]
17 Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, Kaluza G, Pumpens P, Gerlich WH. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol. 2000;81:369-378. [PMID: 10644835 DOI: 10.1099/0022-1317-81-2-369] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
18 Vandepapelière P, Lau GK, Leroux-Roels G, Horsmans Y, Gane E, Tawandee T, Merican MI, Win KM, Trepo C, Cooksley G, Wettendorff M, Ferrari C; Therapeutic HBV Vaccine Group of Investigators. Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. Vaccine 2007;25:8585-97. [PMID: 18031872 DOI: 10.1016/j.vaccine.2007.09.072] [Cited by in Crossref: 122] [Cited by in F6Publishing: 117] [Article Influence: 8.1] [Reference Citation Analysis]